Cargando…
Management of aplastic anemia during the phase of defervescence of the COVID-19 pandemic()
Autor principal: | Vallejo Llamas, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220937/ https://www.ncbi.nlm.nih.gov/pubmed/34179500 http://dx.doi.org/10.1016/j.medcle.2021.02.003 |
Ejemplares similares
-
Early Defervescence and SARS Recovery
por: Wang, Jann-Tay, et al.
Publicado: (2004) -
Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic
por: Sakurai, Masatoshi, et al.
Publicado: (2023) -
Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010) -
Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013) -
Lessons from a patient with severe aplastic anemia complicated with COVID-19
por: Wang, Yang, et al.
Publicado: (2021)